Lecanamab: Controversial Alzheimer’s drug approved by Australian drugs regulator after two rejections Post date 30 September 2025 ← Palantir: Doctors urge major health think tank to cut ties with controversial technology company → NHS online hospital: Health leaders question where money and staff will come from for Labour’s new service